Search
Skip to Search Results
Filter
Author / Creator / Contributor
- 1Baracos, Vickie E.
- 1Bekaii-Saab, Tanios
- 1Doyle, L. Austin
- 1Ghosh, Sunita
- 1Prado, Carla M.
- 1Sawyer, Michael B.
Subject / Keyword
Year
Collections
Languages
Item type
-
Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: Selumetinib in patients with cholangiocarcinoma
Download2012
Ghosh, Sunita, Doyle, L. Austin, Baracos, Vickie E., Prado, Carla M., Sawyer, Michael B., Bekaii-Saab, Tanios, Shrestha, Suraj
background: Cancer cachexia is characterised by skeletal muscle wasting; however, potential for muscle anabolism in patients with advanced cancer is unproven. methods: Quantitative analysis of computed tomography images for loss/gain of muscle in cholangiocarcinoma patients receiving selumetinib...
1 - 1 of 1